Showing drug card for Abarelix (DB00106)
Secondary Accession Number
Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
(abarelix) for Injectable Suspension
Immediate-onset systemic allergic reactions, some resulting in
, have occurred after administration of Plenaxis™. These immediate-onset reactions have been reported to occur following any administration of Plenaxis™, including after the initial
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0